Alen Lalic is the Founder and CEO of Clinical Trial Scan and the founder of Predictive Enrollment Engineering™, the probability-funnel methodology behind DYNO Ai™ enrollment forecasting.
Recruitment is modeled as eight separate steps: answering the call, passing the phone pre-screen, booking a visit, showing up, medical records confirming eligibility, attending screening, passing screening, and enrolling. Each step has its own probability from the protocol's criteria and our own call and visit data, simulated 10,000 times.
Beyond the forecast, CT SCAN runs IRB-approved patient advertising, a US-based outreach team calls and pre-screens every lead, and qualified patients are booked into site visits. CTS-360™, our SMO of research sites trained and readied in our methodology, runs the forecast, advertising, outreach and sites as one program for sponsors and CROs.
Email info@clinicaltrialscan.ai or use the Contact page. Price a study yourself from an NCT number on the proposal builder.